Nabriva Therapeutics (NBRVF) Q4 2017 Earnings

16MarExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
-5.6
-3.91
-2.23
-0.54

Details

Expected EPS
-0.57
Actual EPS
-0.61
Surprise EPS
-0.04
Surprise Percent
+7.02%

Description

Nabriva Therapeutics (NBRVF) has reported earnings of -0.61 per share for Q4 2017.

0 Comments

Share your thoughts